
Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19

May 2021
Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia
Eur J Clin Invest. 2020 Oct 31 : e13435.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Twenty-two patients hospitalized with severe COVID-19 were randomized to receive oxygen therapy using a high-flow nasal cannula oxygen system (n=22) or conventional oxygen therapy (n=10). Outcomes of interest included vitals (i.e., heart rate; respiratory rate; PaO2/FiO2 oxygenation index), infection indexes (C-reactive protein [CRP]; procalcitonin [PCT]; white blood cell count; lymphocyte count),...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.